Healthcare >> CEO Interviews >> October 12, 1998

Fred E. Cooper – Biocontrol Technology Inc (bico)

FRED E. COOPER is the Chief Executive Officer and a director of Biocontrol Technology, Inc. (NASDAQ:BICO), a western Pennsylvania company that develops and internationally markets medical and environmental products. Mr. Cooper joined Biocontrol in 1989 and, since 1990 has directed all business aspects of the company. He engineered raising over $130 million to fund the research and development of the company's products, including its Diasensor'1000 noninvasive glucose sensor for diabetics, which is the world's first noninvasive sensor. After graduating from the University of Maryland, where he played football and earned a degree in business marketing and finance, Mr. Cooper held various business positions for the first few years. Always entrepreneurial in nature, Mr. Cooper, just 27 years old, then founded and managed Cooper Leasing Corporation, a company specializing in equipment and venture financing. From there, he merged with a partner and founded Equitable Financial Management, Inc., a financial intermediary company managing all aspects and serving as Executive Vice President until his divestiture of ownership in August 1990. Although established in 1972 (then called Coratomic, Inc.), Biocontrol had never really had a business manager, and Mr. Cooper knew he had his work cut out for him. Not in his vivid imagination, however, could he have realized what an extraordinary task he had assumed. Fortunately for Biocontrol, Mr. Cooper has the imagination, fortitude, and foresight necessary to lead a small corporation through the research and development of a medical device, a venture definitely not for the faint of heart. Without Mr. Cooper's strong leadership, Biocontrol might not have emerged from that ordeal with a viable product now approved for marketing outside the U.S. To help the company survive, Mr. Cooper has followed his strong belief in diversification, concurrently developing whole-body extracorporeal hypothermia treatment and equipment for use in cancer and HIV/AIDS, oil spill clean up products, and a metal alloy coating that may be a replacement for hard chrome. Most of these products are now ready for marketing, and Mr. Cooper has moved Biocontrol from research and development to marketing also a task to test his imagination and fortitude. Profile
TWST: Could you give us a background summary on Biocontrol Technology?

Mr. Cooper: Biocontrol Technology's history goes back to about 1972. It

was founded by David Purdy, who is still the